Frailty as a Model of Aging

Handbook of Models for Human Aging

Volumn , Issue , 2006, Pages 697-702

  Walston, Jeremy D ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882887158     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369391-4/50058-8     Document Type: Chapter

References (27)

1. A.R. Cappola, Q.L. Xue, L. Ferrucci, J.M. Guralnik, S. Volpato and L.P. Fried (2003) Insulin-like growth factor i and interleukin-6 contribute synergistically to disability and mortality in older women. J. Clin. Endocrinol. Metab. 88(5), 2019-2025.
2. A. Chin, M.J. Paw, J.M. Dekker, E.J. Feskens, E.G. Schouten and D. Kromhout (1999) How to select a frail elderly population? A comparison of three working definitions. J. Clin. Epidemiol. 52(11), 1015-1021.
3. M.E. Csete and J.C. Doyle (2002) Reverse engineering of biological complexity. Science 295(5560), 1664-1669.
4. W.B. Ershler and E.T. Keller (2000) Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu. Rev. Med. 51 245-270.
5. L.P. Fried and J. Walston (2003) Frailty and Failure to Thrive. W. Hazzard, J.P. Blass, J.B. Halter, J. Ouslander, M. Tinetti (Eds) Principles of Geriatric Medicine and Gerontology, 5e New York: McGraw-Hill 1487-1502.
6. L.P. Fried, C. Tangen, J. Walston, A. Newman, C.H. Hirsch, J.S. Gottdiener, et al. (2001) Frailty in older adults: Evidence for a phenotype. Journal of Gerontology 56A(3), M1-M11.
7. L.P. Fried, E.C. Hadley, J. Walston, A. Newman, J.M. Guralnik, S. Studenski, et al. (2005) Report from the American Geriatrics Society/National Institute on Aging “Bedside to Bench” conference on a research agenda for frailty in older adults: Towards a better understanding of physiology and etiology. Sci. Aging Knowledge Environ.
8. L.P. Fried and J. Walston (1998) Frailty and failure to thrive. W. Hazzard (Eds) Principles of Geriatric Medicine and Gerontology New York: McGraw-Hill 1387-1402.
9. J. Golomb, A. Kluger, J. Gianutsos, S.H. Ferris, M.J. de Leon and A.E. George (1995) Nonspecific leukoencephalopathy associated with aging. Neuroimaging Clin. N. Am. 5(1), 33-44.
10. Y. Iwasaki, M. Asai, M. Yoshida, T. Nigawara, M. Kambayashi and N. Nakashima (2004) Dehydroepiandrosteronesulfate inhibits nuclear factor-kappab-dependent transcription in hepatocytes, possibly through antioxidant effect. J. Clin. Endocrinol. Metab 89(7), 3449-3454.
11. H. Kitano (2002) Systems biology: A brief overview. Science 295(5560), 1662-1664.
12. D.D. Lazarus, L.L. Moldawer and S.F. Lowry (1993) Insulinlike growth factor-1 activity is inhibited by interleukin-1 alpha, tumor necrosis factor-alpha, and interleukin-6. Lymphokine Cytokine Res. 12(4), 219-223.
13. S. Leng, H. Yang and J. Walston (2004) Decreased cell proliferation and altered cytokine production in frail older adults. Aging Clinical and Experimental Research 16(3), 249-252.
14. S. Leng, P. Chaves, K. Koenig and J. Walston (2002) Serum Interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: A pilot study. J. Am. Geriatr. Soc. 50(7), 1268-1271.
15. S. Leng, Q.L. Xue, Y. Huang, R. Semba, P. Chaves, K. Bandeen-Roche, et al. (2005) Total and differential white blood cell counts and their associations with circulating interleukin-6 levels in community-dwelling older women. J. Gerontol. A. Biol. Sci. Med. Sci. 60(2), 195-199.
16. L.A. Lipsitz (2002) Dynamics of stability: The physiologic basis of functional health and frailty. J. Gerontol. A Biol. Sci. Med. Sci. 57(3), B115-B125.
17. L.A. Lipsitz and A.L. Goldberger (1992) Loss of “complexity” and aging. Potential applications of fractals and chaos theory to senescence [see comments]. JAMA 267(13), 1806-1809.
18. O.L. Lopez, W.J. Jagust, S.T. DeKosky, J.T. Becker, A. Fitzpatrick, C. Dulberg, et al. (2003) Prevalence and classification of mild cognitive impairment in the cardiovascular health study cognition study: Part 1. Arch. Neurol. 60(10), 1385-1389.
19. D.A. Papanicolaou, R.L. Wilder, S.C. Manolagas and G.P. Chrousos (1998) The pathophysiologic roles of interleukin-6 in human disease. Ann. Intern. Med 128(2), 127-137.
20. K. Rockwood (2005) Frailty and its definition: A worthy challenge. Journal of the American Geriatrics Society 53 1069-1070.
21. K. Rockwood, K. Stadnyk, C. MacKnight, I. McDowell, R. Hebert and D.B. Hogan (1999) A brief clinical instrument to classify frailty in elderly people. Lancet 353(9148), 205-206.
22. R. Roubenoff, H. Parise, H.A. Payette, L.W. Abad, R. D'Agostino, P.F. Jacques, et al. (2003) Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: The Framingham Heart Study. Am. J. Med. 1115(6), 429-435.
23. S. Studenski, R.P. Hayes, R.Q. Leibowitz, R. Bode, L. Lavery, J. Walston, et al. (2004) Clinical global impression of change in physical frailty: development of a measure based on clinical judgment. J. Am. Geriatr. Soc. 52(9), 1560-1566.
24. J. Walston, M.A. McBurnie, A. Newman, R. Tracy, W.J. Kop, C.H. Hirsch, et al. (2002) Frailty and activation of the inflammation and coagulation systems with and without clinical morbidities: Results from the Cardiovascular Health Study. Archives of Internal Medicine 162 2333-2341.
25. J. Walston (2004) Frailty—The search for underlying causes. Sci. Aging Knowledge. Environ. 4e
26. J. Walston, E.C. Hadley, L. Ferrucci, J.M. Guralnik, A. Newman, S. Studenski, et al. (2005) Research agenda for frailty in older adults: Towards a better understanding of physiology and etiology. Journal of the American Geriatrics Society
27. J.D. Walston and L.P. Fried (2003) Frailty and its implications for care. R.S.M. Orrison, D.E. Meire (Eds) Geriatric Palliative Care New York: Oxford University Press 93-109.